Newly reported circumstances fell by 20 per cent within the week that ended on 16 January, whereas deaths dropped by 8 per cent.
South Africa, the place the Omicron variant was first sequenced, and which has accounted for the majority of circumstances and deaths, has now recorded a downward development for the previous 4 weeks.
Instances additionally fell throughout the remainder of the continent, with solely North Africa reporting a rise in circumstances, with a 55 per cent spike.
The Omicron variant has now been reported in 36 African international locations, and 169 nations everywhere in the world.
‘But to show the tables’ on COVID
In line with WHO’s Regional Director for Africa, Dr. Matshidiso Moeti, the acceleration, peak and decline of this final wave has been “unmatched”, however its influence has been average, with fewer deaths and decrease hospitalizations.
Regardless of these numbers, Dr. Moeti believes that Africa “has but to show the tables on this pandemic.”
“As long as the virus continues to flow into, additional pandemic waves are inevitable. Africa should not solely broaden vaccinations, but in addition achieve elevated and equitable entry to important COVID-19 therapeutics to avoid wasting lives and successfully fight this pandemic,” she stated.
The present case fatality ratio (the loss of life toll per infections) within the continent stays the very best on the planet, though it dropped over the last two waves of variants.
By way of remedy, sufferers with extreme types of the virus are being handled with corticosteroids and medical oxygen. Corticosteroids are largely obtainable and comparatively reasonably priced, however availability of medical oxygen stays a problem.
As well as, African international locations face main impediments in accessing different therapies as a result of restricted availability and excessive price.
Final week, WHO really useful two new medicine, elevating the variety of WHO authorized therapeutics to 11, and the company is now reviewing the information on two oral drugs that promise to scale back danger of hospitalization.
Following negotiations with the Swiss pharmaceutical firm Roche, the company is supporting the cargo of a restricted variety of vials of Tocilizumab, a drug used to deal with sufferers with extreme circumstances.
Cape Verde and Uganda have already obtained vials. Burkina Faso, Ghana and Tanzania are as a result of obtain some within the subsequent few weeks.
Additional larger-scale deliveries are anticipated, with negotiations underway via the ACT-Accelerator partnership.
For Dr. Moeti, the deep inequity that left Africa behind on vaccines should not be repeated with life-saving therapies.
“Common entry to diagnostics, vaccines and therapeutics will pave the shortest path to the top of this pandemic and no area of the world must be left on the fringes of this endeavour,” she stated.
Regardless that vaccine provides have been on the rise, the speed of vaccination stays low, with simply 10 per cent of the continent’s inhabitants absolutely vaccinated.
Africa has up to now obtained about 500 million vaccine doses and administered 327 million.
In line with Dr. Moeti, important efforts are wanted to ramp up the vaccination to succeed in a broad swathe of the inhabitants.
By mid-2022, the UN-backed COVAX Facility expects to have sufficient provide for all participant international locations to totally vaccinate 45 per cent of their populations.